Microcebus murinus:: a useful primate model for human cerebral aging and Alzheimer's disease?

被引:93
|
作者
Bons, N
Rieger, F
Prudhomme, D
Fisher, A
Krause, KH
机构
[1] Inst BioPARK, F-74160 Archamps, France
[2] Hop Kremlin Bicetre, INSERM, U488, Paris, France
[3] Israel Inst Biol Res, IL-70450 Ness Ziona, Israel
[4] Univ Geneva, Sch Med, Biol Aging Lab, CH-1211 Geneva, Switzerland
关键词
Alzheimer's disease; cerebral aging; lemurian; primate; Microcebus murinus;
D O I
10.1111/j.1601-183X.2005.00149.x
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Age-associated dementia, in particular Alzheimer's disease (AD), will be a major concern of the 21st century. Research into normal brain aging and AD will therefore become increasingly important. As for other areas of medicine, the availability of good animal models will be a limiting factor for progress. Given the complexity of the human brain, the identification of appropriate primate models will be essential to further knowledge of the disease. In this review, we describe the features of brain aging and age-associated neurodegeneration in a small lemurian primate, the Microcebus murinus, also referred to as the mouse lemur. The mouse lemur has a relatively short life expectancy, and animals over 5 years of age are considered to be elderly. Among elderly mouse lemurs, the majority show normal brain aging, whereas approximately 20% develop neurodegeneration. This Microcebus age-associated neurodegeneration is characterized by a massive brain atrophy, abundant amyloid plaques, a cytoskeletal Tau pathology and a loss of cholinergic neurons. While elderly mouse lemurs with normal brain aging maintain memory function and social interaction, animals with age-associated neurodegeneration lose their cognitive and social capacities and demonstrate certain similarities with age-associated human AD. We conclude that M. murinus is an interesting primate model for the study of normal brain aging and the biochemical dysfunctions occurring in age-associated neurodegeneration. Mouse lemurs might also become an increasingly important model for the development of novel treatments in this domain.
引用
收藏
页码:120 / 130
页数:11
相关论文
共 50 条
  • [31] Aging and Alzheimer's disease pathology
    Sengoku, Renpei
    NEUROPATHOLOGY, 2020, 40 (01) : 22 - 29
  • [32] Alzheimer's disease and the aging brain
    Terry, Robert D.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2006, 19 (03) : 125 - 128
  • [33] Androgens, aging, and Alzheimer's disease
    Christian J. Pike
    Emily R. Rosario
    Thuy-Vi V. Nguyen
    Endocrine, 2006, 29 : 233 - 241
  • [34] Acetylcholine, aging, and Alzheimer's disease
    Muir, JL
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 56 (04) : 687 - 696
  • [35] Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer’s disease
    Shuaipeng Ma
    Tong Zang
    Meng-Lu Liu
    Chun-Li Zhang
    Molecular Neurodegeneration, 15
  • [36] Current state of research on non-human primate models of Alzheimer's disease
    Li, Hong-Wei
    Zhang, Ling
    Qin, Chuan
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2019, 2 (04) : 227 - 238
  • [37] Amyloid-β oligomers unveil a novel primate model of sporadic Alzheimer's disease
    Jebelli, Joseph D.
    Piers, Thomas M.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [38] Current state of research on non-human primate models of Alzheimer's disease
    Hong-Wei Li
    Ling Zhang
    Chuan Qin
    Animal Models and Experimental Medicine, 2019, 2 (04) : 227 - 238
  • [39] Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT
    Makedonov, I.
    Black, S. E.
    MacIntosh, B. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (02) : 243 - 250
  • [40] Pathophysiology of Parkinson's disease: The MPTP primate model of the human disorder
    Wichmann, T
    DeLong, MR
    PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 : 199 - 213